Display options
Share it on

Biochem J. 2003 Nov 01;375:785-91. doi: 10.1042/BJ20031050.

Sulphonation of dehydroepiandrosterone and neurosteroids: molecular cloning, expression, and functional characterization of a novel zebrafish SULT2 cytosolic sulphotransferase.

The Biochemical journal

Takuya Sugahara, Yuh-Shyong Yang, Chau-Ching Liu, T Govind Pai, Ming-Cheh Liu

Affiliations

  1. Biomedical Research Center, The University of Texas Health Center, Tyler, TX 75708, USA.

PMID: 12885295 PMCID: PMC1223711 DOI: 10.1042/BJ20031050

Abstract

By searching the zebrafish EST (expressed-sequence tag) database, we have identified two partial cDNA clones encoding the 5' and 3' regions of a putative zebrafish sulphotransferase (ST). Using the reverse transcription-PCR technique, a full-length cDNA encoding this zebrafish ST was successfully cloned. Sequence analysis revealed that this novel zebrafish ST displays 44%, 43% and 40% amino acid identity with mouse SULT2B1, human SULT2B1b and human SULT2A1 ST respectively. This zebrafish ST therefore appears to belong to the SULT2 cytosolic ST gene family. Recombinant zebrafish ST, expressed using the pGEX-2TK prokaryotic expression system and purified from transformed Escherichia coli cells, migrated as a 34 kDa protein upon SDS/PAGE. Purified zebrafish ST displayed a strong sulphonating activity toward DHEA (dehydroepiandrosterone), with a optimum pH of 9.5. The enzyme also exhibited activities toward several neurosteroids with differential K(m) and V(max) values. A thermostability experiment revealed the enzyme to be relatively stable over a temperature range between 20 degrees C and 43 degrees C. Among ten different divalent metal cations tested, Fe2+ and Cd(2+ exhibited small, but significant, stimulatory effects, whereas Hg2+ and Cu2+ displayed considerably stronger inhibitory effects on the DHEA-sulphonating activity of the enzyme. These results constitute the first study on the molecular cloning, expression, and characterization of a zebrafish cytosolic SULT2 ST.

References

  1. Biochem Biophys Res Commun. 2000 May 19;271(3):818-22 - PubMed
  2. J Clin Endocrinol Metab. 1996 Sep;81(9):3147-51 - PubMed
  3. J Steroid Biochem Mol Biol. 2001 Jun;77(4-5):261-9 - PubMed
  4. J Comp Neurol. 2001 Sep 17;438(2):123-35 - PubMed
  5. Biochem Biophys Res Commun. 2001 Oct 19;288(1):280-9 - PubMed
  6. Brain Res. 2001 Nov 30;920(1-2):222-5 - PubMed
  7. Brain Res Brain Res Rev. 2001 Nov;37(1-3):133-40 - PubMed
  8. Front Biosci. 2002 Apr 1;7:d827-33 - PubMed
  9. J Biochem. 2002 Sep;132(3):457-62 - PubMed
  10. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  11. Cancer Res. 1975 Sep;35(9):2482-7 - PubMed
  12. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  13. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4704-7 - PubMed
  14. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3695-8 - PubMed
  15. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  16. J Clin Invest. 1988 Aug;82(2):712-20 - PubMed
  17. Lancet. 1989 Oct 28;2(8670):1048-9 - PubMed
  18. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1051-6 - PubMed
  19. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):85-8 - PubMed
  20. J Biol Chem. 1993 Nov 25;268(33):24720-5 - PubMed
  21. J Clin Endocrinol Metab. 1994 Jan;78(1):234-6 - PubMed
  22. Chem Biol Interact. 1994 Jun;92(1-3):107-17 - PubMed
  23. Eur J Biochem. 1994 Dec 1;226(2):293-301 - PubMed
  24. Neuroreport. 1994 Oct 27;5(16):2093-6 - PubMed
  25. FASEB J. 1997 Jan;11(1):3-14 - PubMed
  26. Recent Prog Horm Res. 1997;52:1-32 - PubMed
  27. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4089-91 - PubMed
  28. Chem Biol Interact. 1998 Feb 20;109(1-3):3-27 - PubMed
  29. Biosci Biotechnol Biochem. 1998 May;62(5):1037-40 - PubMed
  30. J Clin Pharmacol. 1999 Apr;39(4):327-48 - PubMed
  31. Science. 1958 Sep 12;128(3324):575-80 - PubMed
  32. Ann N Y Acad Sci. 1995 Dec 29;774:16-28 - PubMed
  33. Biochem J. 1996 Feb 15;314 ( Pt 1):151-8 - PubMed
  34. J Steroid Biochem Mol Biol. 2001 May;77(2-3):159-65 - PubMed

Substances

MeSH terms

Publication Types